Molecular Marker Testing in Curable Non-Small Cell Lung Cancer-Practice Necessarily Precedes Data.
JAMA oncology(2023)
摘要
This Viewpoint describes the use of broad molecular marker testing in patients with early-stage non-small cell lung cancer
更多查看译文
关键词
molecular marker testing,non–small cell lung cancer—practice,lung cancer—practice
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要